Czibere Akos sold AKTS

July 8, 2026 · Form 4 insider transaction

Czibere Akos sold 30,829 shares of Aktis Oncology, Inc. at $27.95 per share, a transaction worth $861.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
30,829
Price
$27.95
Total value
$861.7K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 8, 2026
Filing dateJuly 10, 2026
Shares owned after4,371
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.5300 to $28.5000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

View the original Form 4 on SEC EDGAR
Czibere Akos sold AKTS: July 8, 2026 | Insider Trading Screener